Quest Diagnostics Inc (DGX) 83.49 $DGX Quest Diagnostics

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Quest Diagnostics Inc (DGX) 83.49 $DGX

Quest Diagnostics Estimates Move Up, Tie-Ups to Add Value
Zacks Equity Research - Zacks Investment Research - Tue Jul 12, 7:31AM CDT
On Jul 11, we issued an updated research report on Quest Diagnostics, Inc. (DGX).
AMSG: 80.70 (+0.44), HCA: 79.70 (+1.30), DGX: 83.49 (+0.48), BIOS: 2.65 (-0.02)

Quest Diagnostics Shares Up 25.2% Since SmarTrend's Buy Recommendation (DGX)
Comtex SmarTrend(R) - Fri Jul 08, 1:35PM CDT
SmarTrend identified an Uptrend for Quest Diagnostics (NYSEGX) on February 18th, 2016 at $65.35. In approximately 5 months, Quest Diagnostics has returned 25.19% as of today's recent price of $81.82.
DGX: 83.49 (+0.48)

24.6% Return Seen to Date on SmarTrend Quest Diagnostics Call (DGX)
Comtex SmarTrend(R) - Fri Jul 01, 1:08AM CDT
SmarTrend identified an Uptrend for Quest Diagnostics (NYSEGX) on February 18th, 2016 at $65.35. In approximately 4 months, Quest Diagnostics has returned 24.57% as of today's recent price of $81.41.
DGX: 83.49 (+0.48)

Quest Diagnostics To Release Second Quarter 2016 Financial Results On July 21
PR Newswire - Thu Jun 30, 9:36AM CDT
Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic information services, announced that it will report second quarter 2016 financial results on Thursday, July 21, 2016, before the market opens. It will hold its quarterly conference call to discuss the results beginning at 8:30 a.m. Eastern Time on that day.
DGX: 83.49 (+0.48)

Quest Diagnostics Poised on Strategic Tie-Ups, New Launches
Zacks Equity Research - Zacks Investment Research - Mon Jun 27, 6:38AM CDT
On Jun 26, 2016, we issued an updated research report on Quest Diagnostics, Inc. (DGX).
HCA: 79.71 (+1.31), MASI: 52.67 (+0.15), DGX: 83.49 (+0.48), CRY: 12.33 (+0.13)

Shares of DGX Up 22.6% Since Uptrend Call on Shares
Comtex SmarTrend(R) - Thu Jun 23, 1:45PM CDT
SmarTrend identified an Uptrend for Quest Diagnostics (NYSEGX) on February 18th, 2016 at $65.35. In approximately 4 months, Quest Diagnostics has returned 22.59% as of today's recent price of $80.12.
DGX: 83.49 (+0.48)

Quest Diagnostics Rises 2.32% on Heavy Volume: Watch For Potential Pullback
Comtex SmarTrend(R) - Wed Jun 22, 12:11PM CDT
Quest Diagnostics (NYSEGX) traded in a range yesterday that spanned from a low of $77.91 to a high of $80.11. Yesterday, the shares gained 2.3%, which took the trading range above the 3-day high of $78.38 on volume of 1.3 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
DGX: 83.49 (+0.48)

Watch for Quest Diagnostics to Potentially Pullback After Gaining 2.32% Yesterday
Comtex SmarTrend(R) - Wed Jun 22, 12:09PM CDT
Quest Diagnostics (NYSEGX) traded in a range yesterday that spanned from a low of $77.91 to a high of $80.11. Yesterday, the shares gained 2.3%, which took the trading range above the 3-day high of $78.38 on volume of 1.3 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
DGX: 83.49 (+0.48)

Quest Diagnostics to Relocate Headquarters to 500 Plaza Drive in Secaucus, NJ
PR Newswire - Mon Jun 20, 4:00AM CDT
Marcus Partners, a value-oriented real estate investor, announced today that Quest Diagnostics Incorporated, (NYSE: DGX), the world's leading provider of diagnostic information services, has signed a 130,200 square foot long term lease on the top four floors of 500 Plaza Drive in Secaucus, NJ, which will serve as the company's new headquarters location.
DGX: 83.49 (+0.48)

Look for Shares of Quest Diagnostics to Potentially Rebound after Yesterday's 1.74% Sell Off
Comtex SmarTrend(R) - Fri Jun 17, 1:48PM CDT
Quest Diagnostics (NYSEGX) traded in a range yesterday that spanned from a low of $75.20 to a high of $77.27. Yesterday, the shares fell 1.7%, which took the trading range below the 3-day low of $75.89 on volume of 780,000 shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.
DGX: 83.49 (+0.48)

Data Diagnostics Healthcare Technology Wins Two 2016 IT World Awards
PR Newswire - Thu Jun 09, 7:00AM CDT
Quest Diagnostics (NYSE: DGX) and Inovalon (NASDAQ: INOV) today announced that Data Diagnostics(TM), a point-of-care health analytics technology, has won two IT World Awards®. The solution earned a gold medal in the IT Products and Services for Healthcare category and a bronze medal for New Products and Services. Other companies to win awards in the New Products and Services category include Dell and Samsung. The Network Products Guide's IT World Awards are provided annually to honor achievement in all facets of the information technology industry.
DGX: 83.49 (+0.48), INOV: 19.77 (-0.14)

Quest Diagnostics to Relocate Corporate Headquarters, Consolidate Office Facilities, in New Jersey
PR Newswire - Mon Jun 06, 5:45AM CDT
Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic information services, will relocate its corporate headquarters from Madison, N.J. to Secaucus, N.J. when its lease expires in September 2017.
DGX: 83.49 (+0.48)

Fit Female College Athletes More Prone to Overreaching than Less Fit Ones, Putting Performance at Risk, Finds New Research Presented at American College of Sports Medicine Annual Meeting
PR Newswire - Thu Jun 02, 12:24PM CDT
Female college athletes at their highest pre-season fitness levels may be more susceptible to overreach in a team sport environment than less fit ones, according to original research being presented at the American College of Sports Medicine Annual (ACSM) Meeting.
DGX: 83.49 (+0.48)

Quest Diagnostics To Speak At The Goldman Sachs 37th Annual Global Healthcare Conference
PR Newswire - Thu Jun 02, 8:10AM CDT
Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic information services, announced that it is scheduled to speak at the Goldman Sachs 2016 Global Healthcare Conference in Rancho Palos Verdes, California. Mark Guinan, the company's Senior Vice President and CFO, will discuss the company's vision, goals and five point strategy. The presentation is scheduled for Tuesday, June 7, 2016 at 11:40 a.m. Eastern Time.
DGX: 83.49 (+0.48)

One Year After Launch, BRCA Share(TM) Open Data Initiative Reveals New Findings on BRCA Gene Mutations Linked to Hereditary Breast and Ovarian Cancer Risk
PR Newswire - Wed Jun 01, 7:11AM CDT
BRCA Share, a public-private BRCA gene datashare initiative, today announced the public release of a large collection of new data on genetic variants in the BRCA1 and BRCA2 genes. Mutations of these genes raise the risk of breast, ovarian and other cancers. The findings are to be presented today at the 6th International Biennial Meeting of Human Variome Project Consortium (HVP6) held at UNESCO headquarters in Paris.
DGX: 83.49 (+0.48), LH: 137.10 (+0.85)

Quest Diagnostics and HCA's HealthONE System Partner to Deliver High-Value and Innovative Laboratory Services at Six Denver-Area HealthONE Hospitals
PR Newswire - Tue May 31, 5:45AM CDT
Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, and the HealthONE System of HCA Healthcare (NYSE: HCA) are teaming up to enhance the quality and value of diagnostic services to patients and their doctors through an agreement for Quest to manage in-patient laboratory operations for six Denver-area hospitals in the HealthONE system.
HCA: 79.71 (+1.31), DGX: 83.49 (+0.48)

Quest Diagnostics Launches Three Genetic Test Panels for Predicting Hereditary Cancer Risk
PR Newswire - Thu May 26, 10:54AM CDT
Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, today announced the availability of three new cancer test services designed to provide clinically actionable insight into an individual's risk of developing hereditary forms of cancer. Part of the company's newly branded Quest Vantage(TM) cancer test menu, the tests and accompanying services are designed to provide physicians and patients with clinically actionable data and related support capabilities, including results interpretation, access to genetic counseling and prior authorization for health plan reimbursement.
DGX: 83.49 (+0.48)

Fitch Rates Quest's Senior Notes 'BBB'; Outlook Stable
BusinessWire - Mon May 23, 10:28AM CDT
Fitch Ratings has assigned a 'BBB' rating to Quest Diagnostics Inc.'s (Quest; NYSE: DGX) USD500 million 10-year senior notes offering. Fitch expects that the net proceeds from the offering will be used to repay outstanding indebtedness under the company's senior unsecured revolving credit facility and its secured receivables credit facility and for general corporate purposes. The Rating Outlook is Stable.
DGX: 83.49 (+0.48)

Quest Diagnostics Announces Proposed Senior Notes Offering
PR Newswire - Mon May 23, 7:42AM CDT
Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic information services, announced today that it intends to offer $500,000,000 aggregate principal amount of senior notes in a public offering made under a shelf registration statement filed with the Securities and Exchange Commission, subject to market and other conditions.
DGX: 83.49 (+0.48)

Fitch Affirms Quest Diagnostics' Ratings at 'BBB'; Outlook Stable
BusinessWire - Fri May 20, 3:52PM CDT
Fitch Ratings has affirmed the ratings of Quest Diagnostics Inc. (Quest; NYSE: DGX) at 'BBB'. The Rating Outlook is Stable.
DGX: 83.49 (+0.48)

Scroll down for more posts ▼

Top 10 Most Recent News Articles

UAE Trust Model Faces Its Hardest Test During Crisis

Updated Category News Views 371

A country’s reputation is usually invisible right up until the machinery rattles. Then people, investors, trading partners and residents stop listening to polished slogans and start watching whether airports function, services hold up, information arrives, and business can keep moving. That was the useful core of Saeed Al Eter’s remarks at Ajman Media Forum 2026: soft...

Continue Reading
FASTEN Data Offers an Early Look at Ladera Closure

Updated Category News Views 130

Femoral access may be the unglamorous part of a valve procedure, but it is where an otherwise tidy case can turn ugly in a hurry. That makes Ladera Medical's full FASTEN data worth a careful look. The company reported results in 55 patients undergoing transfemoral TAVR/TAVI, and the numbers presented at London Valves 2026 suggest its large-bore closure system may address...

Continue Reading
CARsgen's CT1182 Data Opens a Careful New CAR-T Test

Updated Category News Views 100

Six very sick lymphoma patients are not a victory lap, but they can still make the whole cell-therapy field sit up straighter. CARsgen has disclosed first clinical results for CT1182, an in vivo CAR-T candidate built on its CARvivo platform, and the early package is plainly more interesting than the usual preclinical chest-thumping. The company reported three complete...

Continue Reading
DataBeyond Puts AI Sorting Before a Waste Mountain

Updated Category News Views 191

Trash is a lousy place to look for technological glamour, which is precisely why DataBeyond's COP31 appearance deserves a sober look. On November 19 in Antalya, Türkiye, the Hangzhou-based equipment provider used a China Pavilion event to lay out its case for AI, optical sensing and robots in resource recovery. That is not a magic-green headline. It is a practical...

Continue Reading
Mission Inn’s Lights Enter a Tender New Ownership Era

Updated Category News Views 527

A holiday spectacle can outlive the hands that hung its first bulb. Riverside is about to test that truth in public, under millions of tiny lights and the very large shadow of a family departure. The Mission Inn Festival of Lights returns in 2026 without Kelly and Duane Roberts as hotel owners for the first time in more than three decades. Duane Roberts died in 2025, the...

Continue Reading
PettiChat’s Digital Pet Twin Has Real Consumer Pull

Updated Category News Views 389

A Collar Gadget Is Chasing the Empty-House Problem Leave a dog or cat alone for a few hours and plenty of owners turn into amateur detectives. Did the cat eat? Has the dog been pacing? Why was that one weird noise caught on the home camera? Seattle startup PettiChat is trying to turn that itch into a product category with PettiLive!, a screen-based version of a pet that...

Continue Reading
Lymphatic Research Gains Attention Beyond Wellness Claims

Updated Category News Views 488

Ankles leave little clues after a long day: sock grooves, puffiness, that dull heaviness nobody bothers to name. PureHealth Research wants people to look past the usual salt-and-water explanation and consider the lymphatic system, the body’s comparatively unsung network for gathering fluid from tissues and returning it to the bloodstream. Fair enough. This system does...

Continue Reading
Ajman Memory Gives Heritage a Durable Digital Backbone

Updated Category News Views 303

Archives usually get applause only after somebody realizes a piece of history has vanished. Ajman is trying to skip that miserable part. During the Ajman Media Forum 2026, held November 18 and 19 at the Emirates Hospitality Centre, the emirate launched Ajman Memory, a project built to collect, document and preserve photographs, papers and video recording its development....

Continue Reading
Persistent Dry Eye Symptoms Call for a Closer Look

Updated Category News Views 312

Eyes can turn into a stubborn little nuisance long before people realize something more complicated is going on. A bottle of artificial tears is easy to grab, cheap enough, and often perfectly sensible for a rough day of screens, wind, reading, or air conditioning. But Dr. Harlan Snyder’s point is the one worth sitting with: when dryness keeps barging back despite...

Continue Reading
PHONO's 150 MW RE+ Win Tests Its U.S. Solar Staying Power

Updated Category News Views 534

A trade-show order book is not cash in the bank, but 150 MW is still a number worth circling in red. PHONO used RE+ 2026 in Las Vegas, held November 17 through 19, to celebrate 20 years in business, parade its solar and storage lineup, and announce new U.S. orders. In a solar market that has become touchier about provenance, compliance and delivered economics, the company...

Continue Reading

Top 5 Most Recently Viewed Articles

Kochav Defense Offers Class A Shares for Independent Trading

Updated Category News Views 100

Kochav Defense Initiates Separate Trading of Class A Shares Kochav Defense Acquisition Corp. (NASDAQ: KCHVU) has exciting news for its investors! Starting July 21, 2025, holders of the unit shares sold during its initial public offering will have the option to trade their Class A ordinary shares and rights separately. This development is expected to provide additional...

Continue Reading
CITGO Takes Active Steps in Community Safety Drills

Updated Category News Views 234

CITGO Lake Charles Refinery completed a significant emergency response drill back in 2024, engaging over 130 participants including local, state, and federal emergency responders. This Worst-Case scenario drill simulated operations on the waterway to bolster command capabilities during potential environmental incidents. Emergency Preparedness: The Core of CITGO's...

Continue Reading
Exploring Premium REITs for Reliable Cash Flow Generation

Updated Category News Views 196

Understanding High-Yield REIT Investments Investing in high-yield real estate investment trusts (REITs) is a popular strategy for those seeking attractive dividend income. REITs are uniquely designed to channel income back to their shareholders, making them an appealing choice for generating passive income streams. This article will explore several high-yield REITs that...

Continue Reading
Orchestra BioMed Strengthens Board with Industry Veteran

Updated Category News Views 180

Introduction of Christopher Cleary to the Orchestra BioMed Board Orchestra BioMed Holdings, Inc. (Nasdaq: OBIO) is thrilled to announce a significant addition to its Board of Directors. Christopher Cleary, a monumental figure in the medical device industry, has joined the team as an independent member effective January 30, 2025. With over three decades of experience in...

Continue Reading
Microsoft's Latest Buyback Plan: What Investors Should Know

Updated Category News Views 202

Microsoft's Strategic Financial Moves Microsoft is making significant investments in its key areas while also ensuring it rewards its shareholders. As the tech giant ramps up its capital expenditures to improve cloud infrastructure—especially for artificial intelligence (AI)—it’s also keen on providing returns to its investors. Recently, the company announced a 10%...

Continue Reading